These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18798866)

  • 1. Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy.
    Bonacchi M; Nistri S; Nanni C; Gelsomino S; Pini A; Cinci L; Maiani M; Zecchi-Orlandini S; Lorusso R; Fanti S; Silvertown J; Bani D
    J Cell Mol Med; 2009 Sep; 13(9B):3437-48. PubMed ID: 18798866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling.
    Formigli L; Perna AM; Meacci E; Cinci L; Margheri M; Nistri S; Tani A; Silvertown J; Orlandini G; Porciani C; Zecchi-Orlandini S; Medin J; Bani D
    J Cell Mol Med; 2007; 11(5):1087-100. PubMed ID: 17979884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prominent role of relaxin in improving postinfarction heart remodeling.
    Bani D; Nistri S; Formigli L; Meacci E; Francini F; Zecchi-Orlandini S
    Ann N Y Acad Sci; 2009 Apr; 1160():269-77. PubMed ID: 19416202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat model.
    Di Lascio G; Harmelin G; Targetti M; Nanni C; Bianchi G; Gasbarri T; Gelsomino S; Bani D; Orlandini SZ; Bonacchi M
    Tex Heart Inst J; 2012; 39(4):488-99. PubMed ID: 22949764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.
    Beiert T; Knappe V; Tiyerili V; Stöckigt F; Effelsberg V; Linhart M; Steinmetz M; Klein S; Schierwagen R; Trebicka J; Roell W; Nickenig G; Schrickel JW; Andrié RP
    Int J Cardiol; 2018 Jan; 250():21-28. PubMed ID: 29169754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin remodels fibrotic healing following myocardial infarction.
    Samuel CS; Cendrawan S; Gao XM; Ming Z; Zhao C; Kiriazis H; Xu Q; Tregear GW; Bathgate RA; Du XJ
    Lab Invest; 2011 May; 91(5):675-90. PubMed ID: 21221074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration.
    Nistri S; Pini A; Sassoli C; Squecco R; Francini F; Formigli L; Bani D
    J Cell Mol Med; 2012 Mar; 16(3):507-19. PubMed ID: 21554533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures.
    Formigli L; Francini F; Nistri S; Margheri M; Luciani G; Naro F; Silvertown JD; Orlandini SZ; Meacci E; Bani D
    J Mol Cell Cardiol; 2009 Aug; 47(2):335-45. PubMed ID: 19465027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of relaxin on myocardial ischemia injury induced by isoproterenol.
    Zhang J; Qi YF; Geng B; Pan CS; Zhao J; Chen L; Yang J; Chang JK; Tang CS
    Peptides; 2005 Sep; 26(9):1632-9. PubMed ID: 16112403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.
    Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
    Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure.
    Zheng G; Cai J; Chen X; Chen L; Ge W; Zhou X; Zhou H
    Biol Pharm Bull; 2017; 40(7):960-966. PubMed ID: 28674260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic progress and future therapeutic perspectives of relaxin in ischemic heart disease.
    Bani D; Nistri S; Sacchi TB; Bigazzi M
    Ann N Y Acad Sci; 2005 May; 1041():423-30. PubMed ID: 15956740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.
    Beiert T; Tiyerili V; Knappe V; Effelsberg V; Linhart M; Stöckigt F; Klein S; Schierwagen R; Trebicka J; Nickenig G; Schrickel JW; Andrié RP
    Biochem Biophys Res Commun; 2017 Aug; 490(3):643-649. PubMed ID: 28634079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified human myoblasts with eNOS may improve regenerative ability of myogenic stem cells to infarcted heart.
    Janeczek A; Zimna A; Rozwadowska N; Fraczek M; Kucharzewska P; Ruciński M; Mietkiewski T; Kolanowski T; Malcher A; Kurpisz M
    Kardiol Pol; 2013; 71(10):1048-58. PubMed ID: 24197586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype.
    Du XJ; Samuel CS; Gao XM; Zhao L; Parry LJ; Tregear GW
    Cardiovasc Res; 2003 Feb; 57(2):395-404. PubMed ID: 12566112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
    Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
    J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing?
    Reinecke H; Murry CE
    Cardiovasc Pathol; 2000; 9(6):337-44. PubMed ID: 11146303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy.
    Samuel CS; Hewitson TD; Zhang Y; Kelly DJ
    Endocrinology; 2008 Jul; 149(7):3286-93. PubMed ID: 18388190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin-induced increased coronary flow through stimulation of nitric oxide production.
    Bani-Sacchi T; Bigazzi M; Bani D; Mannaioni PF; Masini E
    Br J Pharmacol; 1995 Sep; 116(1):1589-94. PubMed ID: 8564223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.